Ambey Laboratories Limited (NSE:DHANSA)
25.00
0.00 (0.00%)
At close: May 29, 2026
Ambey Laboratories Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 24.96 | 17.63 | 3.8 | 4.09 | 2.89 |
Short-Term Investments | - | - | 7.81 | 6.04 | - |
Cash & Short-Term Investments | 24.96 | 17.63 | 11.62 | 10.14 | 2.89 |
Cash Growth | 41.60% | 51.79% | 14.57% | 250.80% | -43.44% |
Accounts Receivable | 539.01 | 404.32 | 186.88 | 35.65 | 85.24 |
Other Receivables | - | - | - | - | 1.78 |
Receivables | 621.76 | 404.32 | 186.88 | 35.65 | 87.02 |
Inventory | 315.42 | 299.13 | 205.75 | 171.2 | 107.51 |
Prepaid Expenses | - | 1.8 | 2.76 | 1.68 | 0.48 |
Other Current Assets | 49.93 | 142.44 | 77.22 | 60.52 | 46.33 |
Total Current Assets | 1,012 | 865.32 | 484.23 | 279.19 | 244.23 |
Property, Plant & Equipment | 466.49 | 382.03 | 270.53 | 242.18 | 241.11 |
Other Intangible Assets | 4.44 | 5.77 | 7.59 | 9.99 | 9.77 |
Long-Term Deferred Tax Assets | 14.68 | 14.21 | 26.76 | 3.86 | 59.7 |
Other Long-Term Assets | - | 4.79 | 5 | 4.55 | 4.48 |
Total Assets | 1,509 | 1,272 | 794.12 | 539.77 | 559.29 |
Accounts Payable | 62.77 | 66.31 | 148.04 | 162.05 | 148.75 |
Accrued Expenses | - | 21.29 | 17.27 | 17.48 | 11.32 |
Short-Term Debt | 207.46 | 137.27 | 22.84 | 4.21 | - |
Current Portion of Long-Term Debt | - | 163.68 | 110.38 | 9.19 | 37.43 |
Current Income Taxes Payable | - | 5.79 | 9.95 | 22.42 | 17.36 |
Other Current Liabilities | 57.02 | 1.44 | 1.96 | 0.99 | 0.96 |
Total Current Liabilities | 327.25 | 395.78 | 310.44 | 216.33 | 215.82 |
Long-Term Debt | 189.25 | 107.48 | 163.22 | 132.03 | 143.06 |
Pension & Post-Retirement Benefits | - | 4.85 | 4.95 | - | 4.76 |
Other Long-Term Liabilities | 4.19 | 0.51 | 0.38 | - | 4.99 |
Total Liabilities | 520.69 | 508.62 | 478.98 | 348.36 | 368.63 |
Common Stock | 249.47 | 249.47 | 186.89 | 177.49 | 177.49 |
Additional Paid-In Capital | - | 375.07 | 37.11 | - | - |
Retained Earnings | - | 33.96 | -13.86 | -91.08 | 13.17 |
Comprehensive Income & Other | 739.01 | 105 | 105 | 105 | - |
Shareholders' Equity | 988.48 | 763.5 | 315.13 | 191.41 | 190.67 |
Total Liabilities & Equity | 1,509 | 1,272 | 794.12 | 539.77 | 559.29 |
Total Debt | 396.71 | 408.43 | 296.44 | 145.42 | 180.49 |
Net Cash (Debt) | -371.74 | -390.8 | -284.83 | -135.28 | -177.6 |
Net Cash Per Share | -14.88 | -16.81 | -15.67 | -7.62 | -35.19 |
Filing Date Shares Outstanding | 25.05 | 24.95 | 18.69 | 17.75 | 17.75 |
Total Common Shares Outstanding | 25.05 | 24.95 | 18.69 | 17.75 | 17.75 |
Working Capital | 684.84 | 469.54 | 173.79 | 62.86 | 28.41 |
Book Value Per Share | 39.46 | 30.61 | 16.86 | 10.78 | 10.74 |
Tangible Book Value | 984.05 | 757.73 | 307.54 | 181.43 | 180.89 |
Tangible Book Value Per Share | 39.29 | 30.37 | 16.46 | 10.22 | 10.19 |
Land | - | 109.95 | 109.95 | 109.95 | 109.95 |
Buildings | - | 79.65 | 79.65 | 79.48 | 77.92 |
Machinery | - | 372.2 | 359.7 | 350.58 | 323.84 |
Construction In Progress | - | 156.64 | 38.37 | - | - |